Skip to main content

. 1963 Aug 10;2(5353):359–361. doi: 10.1136/bmj.2.5353.359

Double-bling Trial of Benziodarone in Angina Pectoris

Paget Davies, Samuel Oram, M P Curwen

PMCID: PMC1872469 PMID: 14025425

359

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BEKAERT J., AUBERT P. [Clinical research on Ampiivix, a new coronary vasodilator substance]. Ther Umsch. 1961 Aug;18:317–321. [PubMed] [Google Scholar]
BEKAERT J., DELTOUR G., BROEKHUYSEN J. [Research on the benzofuran series. III. Study of the thyroid function in man during the administration of an iodized bensofuran derivative (Benziodarone)]. Arch Int Pharmacodyn Ther. 1961 Jul 1;132:339–348. [PubMed] [Google Scholar]
BREDMOSE P. [Amplivix, a new agent for angina pectoris]. Ugeskr Laeger. 1962 Jun 22;124:941–942. [PubMed] [Google Scholar]
DAILHEU-GEOFFROY P., NATAF J. [First clinical trials with a new coronary vasodilator agent: benziodarone]. Presse Med. 1961 May 6;69:971–973. [PubMed] [Google Scholar]
GILLOT P. [Therapeutic value of L-2329 in angina pectoris]. Acta Cardiol. 1959;14:494–515. [PubMed] [Google Scholar]
GORLIN R., BRACHFELD N., MESSER J. V., TURNER J. D. Physiologic and biochemical aspects of the disordered coronary circulation. Ann Intern Med. 1959 Oct;51:698–706. doi: 10.7326/0003-4819-51-4-698. [DOI] [PubMed] [Google Scholar]
JOHNSEN T. S. [Amplivix therapy of angina pectoris. Double blind experiment]. Ugeskr Laeger. 1962 Jun 22;124:942–945. [PubMed] [Google Scholar]
KLOSTER J. H. [Amplivix in the treatment of angina pectoris]. Ugeskr Laeger. 1962 Jun 22;124:939–941. [PubMed] [Google Scholar]
ORAM S., SOWTON E. Failure of propatylnitrate and pentaerythritol tetranitrate to prevent attacks of angina pectoris. Br Med J. 1961 Dec 30;2(5269):1745–1746. doi: 10.1136/bmj.2.5269.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
RISEMAN J. E., ALTMAN G. E., KORETSKY S. Nitroglycerin and other nitrites in the treatment of angina pectoris; comparison of six preparations and four routes of administration. Circulation. 1958 Jan;17(1):22–39. doi: 10.1161/01.cir.17.1.22. [DOI] [PubMed] [Google Scholar]
RUSSEK H. I. Evaluation of drugs used in the treatment of angina pectoris by means of exercise-electrocardiographic tests. Ann N Y Acad Sci. 1956 Nov 16;64(4):533–539. doi: 10.1111/j.1749-6632.1956.tb36826.x. [DOI] [PubMed] [Google Scholar]
SHARPEY-SCHAFER E. P., GINSBURG J. Humoral agents and venous tone. Effects of catecholamines, 5-hydroxytryptamine, histamine, and nitritex. Lancet. 1962 Dec 29;2(7270):1337–1340. doi: 10.1016/s0140-6736(62)91018-8. [DOI] [PubMed] [Google Scholar]
VASTESAEGER M. M., ROCHET J., LELOUP A. [The action of Benziodarone in anginal syndromes]. Sem Hop Ther Paris. 1961 Dec;37:937–940. [PubMed] [Google Scholar]

ACTIONS

RESOURCES